Atlas Trials

Comparative Study of Sitagliptin and Gliclazide With Metformin in Type 2 Diabetes Patients With Glucotoxicity

Clinical trial NCT06613750 · COMPLETED

Trial details

NCT number
NCT06613750
Sponsor
Zhibin Xu
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Type 2 Diabetes MellitusGlucotoxicity
Start date
2024-06-01
Primary completion
2024-06-30
Enrollment
129

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.